Collins Nakai RL, McLaughlin P

Language: English
References: 11
Page: 429-431
PDF size: 38.83 Kb.

ABSTRACT

Congenital cardiovascular abnormalities may result in cerebrovascular complications such as brain abscess or the increasingly recognized cognitive defects following bypass pump surgery. However, stroke of various kinds are the most common cerebrovascular complication of cardiovascular diseases. Cardiovascular associations with stroke include atrial fibrillation/flutter, emboli from prosthetic heart valves, cerebral ischemia secondary to myocardial infarction or dysfunction, emboli secondary to LV dysfunction, infective endocarditis, tumors, LV aneurysm, atrial septal aneurysms, mitral valve prolapse and to paradoxical emboli from patent foramen ovale. Given the importance of hemostasis and thrombosis in cardiovascular diseases, and the increasing human suffering and toll taken by stroke, the contribution of patent foramen ovale to cryptogenic stroke is dis.

REFERENCES

1. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, et al: Prevalence of Patent Foramen Ovale in Patients with Stroke. NEJM 1988; 318(18): 1148-52.

2. Webster MWI, Chancellor AM, Smith HJ, Swift DL, Sharpe DN, Bass NM, et al: Patent Foramen Ovale in Young Stroke Patients. Lancet 1988: 11-12.

3. Windecker S, Meier B: Patent Foramen Ovale and Atrial Septal Aneurysm: When and How Should they be Treated? ACC Curr J Rev 2002; 11: 97-101.

4. Comess KA, De Rook FA, Beach KW et al: Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: prevalence of findings and recurrent stroke risk. J Am Coll Card 1994; 23: 1598-1603.

5. Stone DA, Godard J, Corretti MC, Kittner SJ, Sample C, Price TR, et al: Patent foramen ovale: Association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events. Amer Heart J 1996; 131(1): 158-61.

6. Mohr JP, Thompson JLP, Lazar RM, Levin B, Sacco RL,Furie KL, et al: A Comparison of Warfarin and Aspirin for the Prevention of Recurrent Ischemic Stroke. NEJM 2001; 345(20): 1444-1451.

7. Powers WJ: Oral Anticoagulation Therapy for the Prevention of Stroke. NEJM 2001; 345(20): 1493-95.

8. Meier B, Lock JE: Contemporary Management of Patent Foramen Ovale. Circ 2003; 107: 5-9.

9. Hong TE, Thaler D, Brorson J, Heitschmidt M, Hijazi ZM, for the Amplatzer PFO investigators: Transcatheter Closure of Patent Foramen Ovale Associated with Paradoxical Embolism Using the Amplatzer PFO Occluder:Initial and Intermediate-term Results of the US Multicenter Clinical Trial. Catheter Cardiovasc Interv 2003; 60: 524-528.

10. Wahl A, Meier B, Haxel B, et al: Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism. Neurology 2001; 57: 1330-1332.

11. Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K, et al: Incidence and Clinical Course of Thrombus Formation on Atrial Septal Defect and Patient Foramen Ovale Closure Devices in 1,000 Consecutive Patients. J Amer Coll Card 2004; 43: 302-9.